SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821825-22-000012
Filing Date
2022-11-04
Accepted
2022-11-03 17:58:50
Documents
84
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ogn-20220930.htm   iXBRL 10-Q 2214373
2 EX-31.1 ogn9302022ex311.htm EX-31.1 7688
3 EX-31.2 ogn9302022ex312.htm EX-31.2 7809
4 EX-32.1 ogn9302022ex321.htm EX-32.1 3467
5 EX-32.2 ogn9302022ex322.htm EX-32.2 3486
  Complete submission text file 0001821825-22-000012.txt   10131085

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogn-20220930.xsd EX-101.SCH 62907
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ogn-20220930_cal.xml EX-101.CAL 76231
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ogn-20220930_def.xml EX-101.DEF 303438
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogn-20220930_lab.xml EX-101.LAB 711730
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogn-20220930_pre.xml EX-101.PRE 476560
78 EXTRACTED XBRL INSTANCE DOCUMENT ogn-20220930_htm.xml XML 2230698
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

IRS No.: 464838035 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40235 | Film No.: 221359481
SIC: 2834 Pharmaceutical Preparations